VUZI Vuzix Corporation Options Ahead of EarningsAnalyzing the options chain and the chart patterns of VUZI Vuzix Corporation prior to the earnings report this week,
I would consider purchasing the 2usd strike price Calls with
an expiration date of 2025-1-17,
for a premium of approximately $0.10.
If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
Vuzix
VUZIVuzix (NASDAQ:VUZI) shares gained more than 15 percent, closing near its highs of the day on strong volume. The stock broke through resistance and out of flag formation. Looks good to go here. Its technical chart shows some bullish signals as both MACD and KD are now going up and the stock breaks above the 200 exp day moving average. Next resistance is now seen at $15.72 Long setup on watch.
VUZI - longI think with the push today wee saw the confirmation that $VUZI is likely bottomed and move up from here, for anyone who want information from the company, im just watching now a video about the annual shareholder meeting 21':
www.youtube.com
I will manually update the progress in the trade, I have no TP and will watch the stock manually to close - derisk or let it run - how it comes. Hope we can profit together.
VUZIX- AR smart glasses/wearable to displace the smartphone?AR smart glasses hype fizzled out after the colossal failure of Google Glasses years ago.
However, according to BTIG, wearable technology's potential TAM could be $100B after accounting for the recent advancement in mobile technology, edge computing and 5G networks. Furthermore, the adoption rate is accelerating because of the rising trend and demand for virtual healthcare, remote training and service calls for overstretched field technicians as a result of on-going pandemic. Based on these factors, BTIG assigns VUZIX a buy rating and $30 price target.
Back in December, VUZIX revealed that Plug Power had been using VUZIX's smart glasses for its remote onboarding and training program and so did Euvirotainer.
Yesterday, Vuzix announced that the company's Vuzix M400 Smart Glasses were featured in the American Medical Association's Special COVID-19 Edition and ARK invest scooped up 292K shares for its ARK Autonomous Technology & Robotics ETF.
Undoubtedly, the momentum and short/long-term catalysts are on VUZIX's side, but the profitability and value leave much to be desired. VUZIX's growth depends on how well it can position itself to grab a slice of the pie in the massive wearable device market.
There might be a temporary pullback to the bottom of channel as the price seems slightly overextended judging from bearish divergences and trend indicators. However, volume seems healthy and I place more emphasis on volume analysis vs technical indicators. Either way, I treat it as an asymmetrical bet with the massive upside potential hinged upon the convergence of multiple technological breakthrough and enterprise adoption. I would open up a small position and put in 1/2 market buy and put in the rest at the bottom of the channel with the stoploss placed directly below the channel. This swing/intermediate setup can turn into the long-term holding if fundamental plays out in the long run.
Do your own due diligence. Not the investment advice.